CASE STUDY

Accelerated Cancer Target ID by 75% with ML & Curated Data

Key Highlights

  • The company aimed to find targets for differentiation therapy for cancers including AML.
  • Data retrieval, harmonization and ML model development are time-consuming.
  • To help the company circumvent the time factor, Elucidata curated an omics data atlas and developed custom pipelines.
  • The company was able to identify two targets in 2-3 months compared to the 1-2 years that it generally takes.
Get your case study now
Please enter only business email ids.
Thank you for showing interest!
You will receive the Case Study in your Mailbox shortly.

To know more about us, book a demo here.
Oops! Something went wrong while submitting the form.

All Case Studies

Case study: Accelerated Target ID using ML-Ready data on Polly

The Last Mile of Public Dataset Discovery: Polly Scout vs. Claude's Native Search

Read More
Case study: Accelerated Target ID using ML-Ready data on Polly

Identifying and Prioritizing AML Targets via Reconstructed Cell-Type Resolution from Bulk Transcriptomics Data

Read More
Case study: Accelerated Target ID using ML-Ready data on Polly

Generative AI Workflow Cuts Regulatory Reporting Time by 4X for Leading RNAi Therapeutics Company

Read More
Case study: Accelerated Target ID using ML-Ready data on Polly

Data-Centric Cross-Species Target Discovery with Polly KG

Read More
Case study: Accelerated Target ID using ML-Ready data on Polly

Polly Knowledge Graph (KG): Co-built, evidence-backed biology for target discovery & validation

Read More
Case study: Accelerated Target ID using ML-Ready data on Polly

Data-Driven Capacity Modeling with Agentic AI

Read More
Request Demo